3M Announces a Technical Collaboration on New MDI Projects with Novartis; Novartis NCEs and 3M Inhalation Expertise to be Combined.Business Editors & Health/Medical Writers ST. PAUL St. Paul as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26] See : Bravery , Minn.--(BUSINESS WIRE)--April 9, 2002 3M Drug Delivery Systems (DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S ) Division announced today that the company has entered into an agreement with Novartis Pharma AG to explore future development and manufacturing opportunities for a range of new Novartis inhalation products. Further details on the agreement are not available at this time. "3M DDS is excited about our collaborative relationship with Novartis on developing their pipeline of inhalation products that will be delivered via metered dose inhalers (MDIs)," said John Sampson John Sampson is the name of:
J. Brokatzky-Geiger, head of Worldwide Technical Research & Development, Novartis Pharma, said, "The market for inhalation products is expanding rapidly worldwide and Novartis is extremely well-positioned to provide care for the millions of patients who desire MDI-delivered products." Pointing out that Novartis currently has several inhalation NCEs in development, Brokatzky-Geiger said further, "Working with 3M DDS, one of the leading global providers of MDI systems, ensures that Novartis' new products will reflect the latest in MDI technology as we move towards commercialization." About 3M DDS 3M DDS is a global leader in the development of inhalation and transdermal technologies. As the creator of the first metered dose inhaler inhaler /in·hal·er/ (in-hal´er) 1. an apparatus for administering vapor or volatilized medications by inhalation. 2. ventilator (2). in·hal·er n. (MDI), the division has a 45-year history of medical innovation, including introduction of the world's first HFA HFA Harvard Film Archive (Harvard University) HFA Harry Fox Agency, Inc. HFA Housing Finance Agency (District of Columbia government) HFA Hyogo Framework for Action HFA High-Functioning Autism inhalers. Today, 3M DDS components and services are used in over 50 percent of all global MDI devices. Likewise, the company also pioneered the Latitude transdermal drug delivery system, a drug-in-adhesive platform that can be customized for a variety of therapeutic agents, while delivering medication through a patient's skin for up to a week. Over 80 percent of transdermal systems in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. contain at least one 3M DDS component. About 3M 3M is a $16 billion diversified technology company with leading positions in health care, safety, electronics, telecommunications, industrial, consumer and office, and other markets. Headquartered in St. Paul, Minnesota, the company has operations in more than 60 countries and serves customers in nearly 200 countries. 3M businesses share technologies, manufacturing operations, brands, marketing channels and other important resources. 3M is one of the 30 stocks that make up the Dow Jones Industrial Average Dow Jones Industrial Average The best known U.S. index of stocks. A price-weighted average of 30 actively traded blue-chip stocks, primarily industrials including stocks that trade on the New York Stock Exchange. and also is a component of the Standard & Poor's 500 Index. For more information about 3M go to www.3M.com or www.3M.com/profile/pressbox/index.jhtml. 3M and Latitude are trademarks of 3M company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion